Skip to main content

Transition Considerations for Congenital Adrenal Hyperplasia

  • Chapter
  • First Online:
Transitioning from Pediatric to Adult Care in Endocrinology
  • 390 Accesses

Abstract

Classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is a condition in which there is a defect in adrenal steroidogenesis leading to defective cortisol production, salt wasting, and varying degrees of hyperandrogenism. This lifelong endocrine condition requires multiple medications, frequent laboratory evaluation, and close monitoring to prevent adverse long-term outcomes. The management of CAH can be challenging, especially during the transition from pediatric to adult care. During adolescence, specific treatment and educational topics for patients and families must be addressed by the medical team to help prepare for managing CAH in adulthood. The aim of this chapter is to discuss management goals in the adolescent period, psychosocial and educational issues specific to CAH that should be addressed with patients and families, and appropriate transition practices from pediatric to adult care.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev. 2000;21(3):245–91.

    CAS  PubMed  Google Scholar 

  2. Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(9):4133–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Turcu AF, Auchus RJ. The next 150 years of congenital adrenal hyperplasia. J Steroid Biochem Mol Biol. 2015;153:63–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Levine LS, Dupont B, Lorenzen F, Pang S, Pollack M, Oberfield SE, et al. Genetic and hormonal characterization of cryptic 21-hydroxylase deficiency. J Clin Endocrinol Metab. 1981;53(6):1193–8.

    Article  CAS  PubMed  Google Scholar 

  5. Moran C, Azziz R, Carmina E, Dewailly D, Fruzzetti F, Ibanez L, et al. 21-hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. Am J Obstet Gynecol. 2000;183(6):1468–74.

    Article  CAS  PubMed  Google Scholar 

  6. Pasterski V, Hindmarsh P, Geffner M, Brook C, Brain C, Hines M. Increased aggression and activity level in 3- to 11-year-old girls with congenital adrenal hyperplasia (CAH). Horm Behav. 2007;52(3):368–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Pasterski V, Geffner ME, Brain C, Hindmarsh P, Brook C, Hines M. Prenatal hormones and childhood sex segregation: playmate and play style preferences in girls with congenital adrenal hyperplasia. Horm Behav. 2011;59(4):549–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Dittmann RW, Kappes ME, Kappes MH. Sexual behavior in adolescent and adult females with congenital adrenal hyperplasia. Psychoneuroendocrinology. 1992;17(2–3):153–70.

    Article  CAS  PubMed  Google Scholar 

  9. Berenbaum SA, Korman Bryk K, Duck SC, Resnick SM. Psychological adjustment in children and adults with congenital adrenal hyperplasia. J Pediatr. 2004;144(6):741–6.

    PubMed  Google Scholar 

  10. Slijper FME, van der Kamp HJ, Brandenburg H, Keizer-Schrama SMPFM, Drop SLS, Molenaar JC. Evaluation of psychosexual development of young women with congenital adrenal hyperplasia: a pilot study. J Sex Educ Ther. 1992;18(3):200–7.

    Article  Google Scholar 

  11. Zucker KJ, Bradley SJ, Oliver G, Blake J, Fleming S, Hood J. Psychosexual development of women with congenital adrenal hyperplasia. Horm Behav. 1996;30(4):300–18.

    Article  CAS  PubMed  Google Scholar 

  12. Strandqvist A, Falhammar H, Lichtenstein P, Hirschberg AL, Wedell A, Norrby C, et al. Suboptimal psychosocial outcomes in patients with congenital adrenal hyperplasia: epidemiological studies in a nonbiased national cohort in Sweden. J Clin Endocrinol Metab. 2014;99(4):1425–32.

    Article  CAS  PubMed  Google Scholar 

  13. Sanches SA, Wiegers TA, Otten BJ, Claahsen-van der Grinten HL. Physical, social and societal functioning of children with congenital adrenal hyperplasia (CAH) and their parents, in a Dutch population. Int J Pediatr Endocrinol. 2012;2012(1):2.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Falhammar H, Thoren M. Clinical outcomes in the management of congenital adrenal hyperplasia. Endocrine. 2012;41(3):355–73.

    Article  CAS  PubMed  Google Scholar 

  15. Charmandari E, Hindmarsh PC, Johnston A, Brook CG. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty. J Clin Endocrinol Metab. 2001;86(6):2701–8.

    Article  CAS  PubMed  Google Scholar 

  16. Auchus RJ, Arlt W. Approach to the patient: the adult with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2013;98(7):2645–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Hagenfeldt KB. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency – the adult woman. Growth Hormon IGF Res. 2004;14(Suppl A):S67–71.

    Article  CAS  Google Scholar 

  18. White PC, Speiser PW. Long-term consequences of childhood-onset congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab. 2002;16(2):273–88.

    Article  PubMed  Google Scholar 

  19. Barnes RB, Rosenfield RL, Ehrmann DA, Cara JF, Cuttler L, Levitsky LL, et al. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab. 1994;79(5):1328–33.

    CAS  PubMed  Google Scholar 

  20. Mueller SC, Ng P, Sinaii N, Leschek EW, Green-Golan L, VanRyzin C, et al. Psychiatric characterization of children with genetic causes of hyperandrogenism. Eur J Endocrinol. 2010;163(5):801–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Claahsen-van der Grinten HL, Otten BJ, Stikkelbroeck MM, Sweep FC, Hermus AR. Testicular adrenal rest tumours in congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab. 2009;23(2):209–20.

    Article  CAS  PubMed  Google Scholar 

  22. Aycan Z, Bas VN, Cetinkaya S, Yilmaz Agladioglu S, Tiryaki T. Prevalence and long-term follow-up outcomes of testicular adrenal rest tumours in children and adolescent males with congenital adrenal hyperplasia. Clin Endocrinol. 2013;78(5):667–72.

    Article  Google Scholar 

  23. Claahsen-van der Grinten HL, Otten BJ, Takahashi S, Meuleman EJ, Hulsbergen-van de Kaa C, Sweep FC, et al. Testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia: evaluation of pituitary-gonadal function before and after successful testis-sparing surgery in eight patients. J Clin Endocrinol Metab. 2007;92(2):612–5.

    Article  CAS  PubMed  Google Scholar 

  24. Kruse B, Riepe FG, Krone N, Bosinski HA, Kloehn S, Partsch CJ, et al. Congenital adrenal hyperplasia – how to improve the transition from adolescence to adult life. Exp Clin Endocrinol Diabetes. 2004;112(7):343–55.

    Article  CAS  PubMed  Google Scholar 

  25. Gleeson H, Davis J, Jones J, O'Shea E, Clayton PE. The challenge of delivering endocrine care and successful transition to adult services in adolescents with congenital adrenal hyperplasia: experience in a single centre over 18 years. Clin Endocrinol. 2013;78(1):23–8.

    Article  Google Scholar 

  26. Bachelot A, Vialon M, Baptiste A, Tejedor I, Elie C, Polak M, et al. Impact of transition on quality of life in patients with congenital adrenal hyperplasia diagnosed during childhood. Endocr Connect. 2017.

    Google Scholar 

  27. CARES Foundation: Congenital Adrenal Hyperplasia Research Education & Support 2018 [Internet]. [cited August 2018]. Available from: www.caresfoundation.org.

  28. Hormone Health Network, The Endocrine Society 2018 [Internet]. [updated September 2017; cited August 2018]. Available from: https://www.hormone.org/diseases-and-conditions/adrenal/congenital-adrenal-hyperplasia.

  29. Congenital adrenal hyperplasia: a guide for families. Pediatric Endocrine Society 2017 [Internet].[cited August 2018]. Available from: https://www.pedsendo.org/assets/patients_families/EdMat/first_batch/Congenital%20adrenal%20hyperplasia.pdf.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bonnie McCann-Crosby .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

McCann-Crosby, B. (2019). Transition Considerations for Congenital Adrenal Hyperplasia. In: Lyons, S., Hilliard, M. (eds) Transitioning from Pediatric to Adult Care in Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-030-05045-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-05045-0_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-05044-3

  • Online ISBN: 978-3-030-05045-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics